Atlas Trials

Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration

Clinical trial NCT06221787 · RECRUITING

Trial details

NCT number
NCT06221787
Sponsor
Fujian Medical University Union Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Melasma
Start date
2022-04-01
Primary completion
2025-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.